AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Consistent with our findings, predominant nuclear expression of FOXO3a have also been shown to correlate with enhanced PI3K/Akt activity and acquisition of chemoresistance in chronic myeloid leukaemia (CML) cell lines [23], [24].